1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Outcome measures
Value
 Platelet function test 
  Yes 89 (100%)
  No 0 (0%)
 Clopidogrel responder 
  Yes 66 (74.2%)
  No 23 (25.8%)
Angiographic outcome 
 Imaging follow-up 
  Median (range) (mo) 27 (9–60)
  Data availability 89/92 (96.7%)
  Long-term imaging follow-up rate with  aneurysm persistent at 6 mo 41/43 (95.3%)
 Occlusion rate at 6 mo 
  Complete (100%) 62 (59.0%)
  Near-complete (90%–99%) 20 (19.0%)
  Partial (<90%) 23 (22.0%)
 Occlusion rate at last follow-up 
  Complete (100%) 74 (70.5%)
  Near-complete (90%–99%) 17 (16.2%)
  Partial (<90%) 14 (13.3%)
 Adjunctive coil 35 (33.3%)
 Retreatment 5 (5.5%)
Clinical outcome 
 Posttreatment mRS 
  0–2 84 (94.4%)
  3–5 5 (5.6%)
  6 (death) 0 (0%)
 mRS at last follow-up 
  Improved 16 (18.0%)
  No change 73 (82.0%)
  Worsened 0 (0%)
 Neurologic complications 
  Thromboembolic 40 (44.0%)
   Symptomatic 6 (6.6%)
  Hemorrhagic 3 (3.3%)
   Symptomatic 0 (0%)
  Symptomatic cranial nerve compression 1 (1.1%)
 Long-term outcome 
  Rupture of aneurysm at follow-up 0 (0%)
  Compression improved at follow-up 10 (37.0%)
  Permanent neurologic complication 0 (0%)
  Permanent neurologic death 0 (0%)